Collections:
Other Resources:
DOI: 10.1182/blood.2021014689
Paper Summary:
Title: Asciminib: new therapeutic option in chronic phase CML with treatment failure.
Author(s): Yeung, David T; Shanmuganathan, Naranie; Hughes, Timothy P
Year: 2022
DOI: 10.1182/blood.2021014689
URL: https://doi.org/10.1182/blood.2021014689
Received on: 2022-10-26
✍: FYIcenter.com
2022-10-26, ∼1175👍, 0💬
Related Topics:
Popular Posts:
Paper Summary: Title: H2-Engine Operation with EGR Achieving High Power and High Efficiency Emission...
Paper Summary: DOI: 10.1080/87559129.2021.19 67377Received on: 2024-06-02
Paper Summary: Title: Diminished immune responses with aging predispose older adults to common and u...
Paper Summary: DOI: 10.2174/1874467215666220 705142954Received on: 2024-10-29
Paper Summary: Title: Socially responsible investments: Institutional aspects, performance, and inve...
